9th Annual Biomarkers Congress

Cancer Biology: National Institutes of Health

Total Score People Score Events Score
237 191 109
Date Event Presentation Speakers
March 5, 2014 Targeted Anticancer Therapies Miscellaneous Drug Targets and Their Inhibitors/Modulators Christina Annunziata
Problems" in Early Drug Development, what can we learn? Len Neckers
February 11, 2014 Jagelman/Turnbull International Colorectal Disease Symposium DEBATE: The best option after a complete response to neoadjuvant therapy is… operation Barbara C. Sorkin
January 23, 2014 T-cell Lymphoma Forum T-cell Lymphoma Forum Thomas A Waldmann
October 27, 2013 Nature - CNIO Cancer Symposium: Frontiers in Tumour Heterogeneity and Plasticity Modeling Pathogenesis of Primary Liver Cancer in Lineage Specific Cell Types Snorri S Thorgeirsson
June 19, 2013 Molecular Diagnostics for Cancer Drug Development Molecular imaging in oncology: Will it deliver the goods? Peter Choyke
June 12, 2013 Montreal International Symposium on Angiogenesis and Metastasis – MISAM-2013 Montreal International Symposium on Angiogenesis and Metastasis – MISAM-2013 Patricia Steeg
May 5, 2013 Mitochondria: from Signalling to Disease Roles of Pink1 kinase and Parkin E3 ligase in mitophagy and Parkinson's disease, IS5.1 Richard J Youle
April 6, 2013 AACR Annual Meetings BRAF Pathway Inhibitors in Melanoma: Where Do We Go from Here? Chairperson: Richard M. Marais, Paterson Institute for Cancer Research, Manchester, United Kingdom Deborah Morrison
The MICR Scientific Symposium: Why Are Aggressive Forms of Cancer More Common Among Certain Racial/Ethnic Groups? Co-Chairpersons: Christopher I. Li, Fred Hutchinson Cancer Research Center, Seattle, WA, and A. William Blackstock, Wake Forest University School of Medicine, Winston-Salem, NC Curtis C. Harris
Lymphoid Malignancies Co-Chairpersons: Peter J. Campbell, Wellcome Trust Sanger Institute, Cambridge, United Kingdom, and Louis M. Staudt, National Cancer Institute, Bethesda, MD Louis M. Staudt
Novel Therapeutic Concepts with Kinases, Immuno-, and Radiotherapy Chairperson: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY W. Marston Linehan
Predictive Modeling of Cancer Treatment in Single Patients (N of 1) Moderator: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY James H. DOROSHOW
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Louis M. Staudt
Immune Reconstitution Following Lymphodepleting Cancer Therapy: Does It Matter? Crystal L. Mackall, National Cancer Institute, Bethesda, MD Crystal Mackall
March 3, 2013 Understanding Dendritic Cell Biology to Advance Disease Therapies (C2) Mice with Conditional Deletion of NF-kappaB–Inducing Kinase (NIK) in Dendritic Cells Show Defective CD40-Dependent Antigen Cross-Priming of CD8+ T Cells C Austin
Short Talk: Commensal Microbiota Modulates the Innate Response to Cancer Immunotherapy and Chemotherapy Romina Silvana Goldszmid
January 20, 2013 Tumor Invasion and Metastasis Epithelial-mesenchymal plasticity in breast cancer metastasis Y Kang
Session 2: Determinants of Tumor Metastasis Y Kang
December 8, 2012 54th American Society of Haematology Annual Meeting and Exposition Career-Development Lunch Sessions Cynthia E. Dunbar
Trainee Simultaneous Didactic Sessions Cynthia E. Dunbar
December 3, 2012 International Conference and Exhibition on Obesity and Weight Management Track 1: Overweight and Obesity - An Overview Tiffany M. Powell-Wiley
August 24, 2012 21st Annual Short Course on Experimental Models of Human Cancer Systems Genetics of Metastasis Susceptibility Kent W. Hunter
May 2, 2012 4th Australasian Vaccines and Immunotherapeutics Development Meeting Session 1: Designing vaccines to induce T cell responses Robert Seder
April 15, 2012 28th IABCR/Breakthrough Breast Cancer Conference Hunting for novel metastasis genes Kent W. Hunter
December 13, 2011 New Horizons in Cancer Research: Biology to Prevention to Therapy Day in Review Curtis C. Harris
Inflammation and cancer: Interweaving microRNA, innate immune, and p53 networks Curtis C. Harris
Concurrent Session 4 | Cancer Genetics Curtis C. Harris
December 9, 2011 2nd Oxford Symposium on Epigenetic Mechanisms in Health and Disease Session 2 | TBA Ian Adcock
November 15, 2011 Cosa 38th Annual Scientific Meeting Best of the Best Orals - Basic and Translational research David Goldstein
CONCURRENT SYMPOSIA | Renal Cell Carcinoma: Learning from the Community David Goldstein
November 12, 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Development of clinical trials incorporating genomic signatures: Lessons learned Lisa M McShane
New paradigms for early-phase clinical trials James H. DOROSHOW
Educational Session 2 | Clinical Trial Paradigms in the Era of Novel Therapies James H. DOROSHOW
Preventing multiple types of cancer through HPV vaccination Douglas R LOWY
August 31, 2011 Strategies for Engineered Negligible Senescence, 5th Conference (SENS5) Zscan4 | a key to telomerase-independent telomere elongation? Minoru Ko
August 21, 2011 The TGF-β Superfamily: Signaling in Development and Disease Smad3 in tumorigenesis-insights from "omics" Lalage M. Wakefield
Session 1 | Signaling Mechanisms I Lalage M. Wakefield
August 7, 2011 Mobile DNA in Mammalian Genomes Conserved repeats | a new outlook on early mammalian radiation Jerzy Jurka
August 5, 2011 Skin Cancer Conference Surgical management of melanoma: what is the evidence and what is best practice? David Wilkinson
Skin Cancer Network | a triumph of philanthropy over disease David Wilkinson
July 30, 2011 MD Anderson Physicians Network Symposium Changing Paradigms in Cancer Treatment and Patient Management When Should We Use MRI in Breast Cancer Follow-Up? Wei Yang
Breast Cancer Screening and the Impact of Breast Density Wei Yang
March 27, 2011 Congress on Steroid Research Neonatal exposure to estrogens or environmental estrogens induces aberrant promoter methylation and expression of nucleosomal binding protein (Nsbp1) in later-life Mitchell Ho
March 27, 2011 Autophagy (D1) Workshop 1: Novel Techniques to Track Autophagy Jennifer Lippincott-Schwartz
Roles of Parkin and Pink1 in Mitophagy Richard J Youle
Mechanisms of Macroautophagic Selectivity Jennifer Lippincott-Schwartz
March 20, 2011 AAA and Related ATP-Driven Protein Machines: Structure, Function and Mechanism (C6) Its all in the Neck | How the ESCRTs Make Multivesicular Bodies James H. Hurley
Cytoskeleton Regulation by AAA+ Proteins: Molecular Dissection of Microtubule Severing Antonina Roll-Mecak
March 3, 2011 Stem Cells, Development, and Cancer Tumor maintenance cells and therapy resistance Professor Meenhard Herlyn
March 1, 2011 "The Latest Advances in Liver Cancer Research: From Basic Science to Therapeutics" Sessions 4 | p53, microRNAs and senescence in human carcinogenesis Curtis C. Harris
February 27, 2011 AACR-NCI Conference on Systems Biology: Confronting the Complexity of Cancer Session 1 | Converging on the Achilles' heel of cancer through functional and structural genomics Louis M. Staudt
February 27, 2011 Signal Transduction within the Nucleus Gordon Research Conference Epigenetic regulation of alternative splicing T Misteli
Transcriptional control by endosomal sorting factors in yeast Alan Hinnebusch
February 17, 2011 15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma Comment Wyndham H. Wilson
Toward Optimal Initial Management of Mantle Cell Lymphoma Wyndham H. Wilson
Lymphoma Wyndham H. Wilson
February 12, 2011 Cancer Control by Tumor Suppressors and Immune Effectors (J8) Adaptive Immunity against Cancer? | Re-Imagining the Ideal Antitumor T Cell Nicholas P. Restifo
Translating Immune Responses Toward and Into the Clinic (Joint) | TLRs in Vaccine Development Robert Seder
February 6, 2011 Salivary Glands & Exocrine Biology Cell and tissue dynamics Kenneth. M. Yamada
A role for the acto-myosin complex in regulated exocytosis revealed by intravital microscopy Roberto Weigert
MicroRNAs regulate proliferation and cell fate decisions Ivan T Rebustini
Exocrine Glycobiology Sarah M. Knox
Protein O-glycosylation in developmentally regulated cell adhesion and organogenesis Kelly TenHagen
MicroRNAs as biomarkers of inflammation and salivary gland dysfunction in Sjögren's syndrome Gabor G. Illei
A little bit nervous? Parasympathetic innervation regulates epithelial progenitor cells Sarah M. Knox
Physiological function of store-operated calcium channels in epithelia and other non-excitable cells James W Putney
Transfer of human aquaporin-1 cDNA to correct radiation-induced salivary hypofunction Ana Cotrim
January 31, 2011 Biomarkers Summit NEW AND INNOVATIVE AND WAYS OF CONDUCTING BIOMARKER R&D Shawnmarie Mayrand-Chung
January 12, 2011 "Nano in Cancer": Linking Chemistry, Biology, and Clinical Applications In Vivo Magnetic labeling of cells: Will we ever get to the clinic Joseph A. Frank
December 8, 2010 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium Statistical challenges in predictive and prognostic biomarker studies: How to avoid wasting your time and specimens Lisa M McShane
November 18, 2010 IV Congress of the International Society of Nutrigenetics/Nutrigenomics ISNN Emerging topics in nutrigenomics and cancer prevention John A. , Milner
November 7, 2010 Ninth Annual International Conference on Frontiers in Cancer Prevention Research Special Session: View From the NCI Robert T. Croyle
Distinguished Lecture on Targets for Cancer Prevention Inflammation and cancer: Interweaving microRNA, innate immune, and p53 pathways Curtis C. Harris
Current and future HPV vaccines Douglas R LOWY
Concurrent Sessions 1 : Infections Douglas R LOWY
Introduction John A. , Milner
Plenary Session 3: Bioenergetics and Cancer John A. , Milner
October 24, 2010 Frontiers in Tumour Progression Two Short Talks Kent W. Hunter
September 27, 2010 Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development Plenary Session 5: Molecular Prediction, Classification, and Prognostic Markers Stephen J Chanock
September 12, 2010 Joint Metastasis Research Society-AACR Conference in Conjunction with the Tumor Microenvironment Working Group of the AACR Targeting TGF-beta to suppress metastasis Lalage M. Wakefield
A LPA1 inhibitor that functions as a metastasis suppressor Jean-Claude A. Marshall
Plenary Session 6: Translational Targets II Patricia Steeg
August 24, 2010 Enabling Point-of-Care Diagnostics - Moving Towards Rapid Diagnosis Retrospective Study, 1918 Pandemic Virus and 2009 H1N1: Lessons for POCT Jeffery K. Taubenberger
Exporting Cervical Cancer Prevention to the Developing World: The Promise and the Challenges Philip E Castle
August 23, 2010 The Ubiquitin Drug Discovery & Diagnostics Conference Structural Insights and Functional Complexity of E2 - RING Finger E3 Interactions Allan Weissman
July 7, 2010 WIN Symposium in personalized cancer medicine Keynote Lecture | Challenges in the development and validation of biomarker signatures for personalized medicine: Lisa M McShane
Phase II and III clinical trial design and endpoints in targeted therapy era-future goals and challenges. Giuseppe Giaccone
May 20, 2010 Bioanalytical Challenges for Optimizing Protein Therapeutics The Mesothelin-CA125/MUC16 Interaction Mitchell Ho
May 20, 2010 Antibody Optimization Deimmunizing Non-Human Proteins Ira Pastan
Chairperson’s Remarks Ira Pastan
April 28, 2010 Kinase Inhibitor Chemistry Targeting the Polo-Box Domain of Polo-Like Knase 1 (Plk1) Kyung S Lee
November 12, 2009 Sixth International Conference - Revitalizing Cancer Care: Comprehensive Interdisciplinary Programs and Whole Systems Research Integrative Healthcare: Towards a Science of Personalized Medicine Wendy B. Smith
September 24, 2009 Track 4: Bridging Silos in Biomarker Development : Seventh Annual Protein Biomarkers Towards a More Efficient Protein Biomarker Development Process Henry Rodriguez
September 23, 2009 Track 3: Advancing Cancer Therapy : Second Annual Translational Cancer Medicine Targeting Tumor Microenvironment Suresh Mohla
August 18, 2009 Second Annual Pre-Clinical/Clinical Development of Immunotherapies and Vaccines Behavioral and Social Science Considerations for Clinical Research Chuen-Yen Lau
August 18, 2009 Inaugural Novel Vaccines: Adjuvants & Delivery Systems Adjuvant Properties of CpG Oligonucleotides Dennis M. Klinman
August 10, 2009 Third Annual Enabling Point-of-Care Diagnostics VALUE OF PUBLIC-PRIVATE PARTNERSHIPS: Highlighting Open Platforms Todd Merchak
August 5, 2009 Drug Safety Strategies to De-Risk Compounds Leveraging Resources to Advance Drug Development: A Consortium Model for Biomarkers Research Shawnmarie Mayrand-Chung
April 7, 2009 Inaugural HIV Inhibitors Featured Presentation: Reverse Transcriptase-Associated Ribonuclease H Activity as a Therapeutic Target Stuart F.J. Le Grice
February 3, 2009 Cancer Health Disparities WORKSHOPS 1 and 2 Vickie Shavers
SPECIAL SESSION: SECONDARY DATA ANALYSIS OF NATIONAL AND STATE HEALTH SURVEY DATA: ACCESS, ANALYSIS, AND FUNDING Richard P Moser, Amy Lazarus Yaroch
PLENARY SESSION 5: THE SCIENCE BEHIND CERVICAL CANCER DISPARITIES Philip E Castle
January 21, 2009 Advances in Prostate Cancer Research FORUM ON BIOMARKERS BEYOND PSA Sudhir Srivastava
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Identification of Novel Modifier Genes of Sox10 Neurocristopathy by a Functional Genomic approach : Track 1-3 Ling Hou
Application of Advanced Technologies to Personalized Oncology: Track 1-7 Francis S Collins
Biological Comparison of Human Anti-AMA1 IgGs :Track 2-9 Kazutoyo Miura
Development of Lentiviral Vectors for Studying on Gene Function, Gene Discovery and Gene Therapy :Track 2-12 Zhennan , Lai
December 1, 2008 European Antibody Congress 2008 Antibody variable and constant domains as scaffolds: domain antibodies and nanoantibodies Dimiter S Dimitriov
November 6, 2008 The 2008 Research Conference on Food, Nutrition, Physical Activity & Cancer Introduction John A. , Milner
Dietary Supplements for Cancer Prevention: How Common and How Useful? Paul Coates
Split Session C: Diet, Supplements and UV Exposure: Defining Optimal Status of Vitamin D and How to Obtain It Mary Frances Picciano
Split Session D: Introduction Johanna T. Dwyer
Split Session D: Interventions to Lower Breast Cancer Risk: Domestic Perspectives Tanya Agurs-Collins
November 4, 2008 The Chemotherapy Foundation Symposium XXVI OR Chemotherapy Foundation Symposium, Innovative Cancer Therapy for Tomorrow MELPHALAN IN NON-COLORECTAL METASTASES TO THE LIVER James , Pingpank
LAPATINIB: PREVENTING METASTATIC COLONIZATION OF BC CELLS IN THE BRAIN Diane Palmieri
LAPULEUCEL-T IN IMMUNOTHERAPY OF BREAST CANCER: CLINICAL TRIAL DATA John Park
TALACTOFERRIN IN REFRACTORY NSCLC Giuseppe Giaccone
NOVEL ANTICANCER AGENTS IN THE NCI CTEP CLINICAL DEVELOPMENT PROGRAM John J. Wright
October 30, 2008 44th ASCO Annual Meeting General Session II: Identifying Patients for EGFR Inhibitor Therapy: Markers of Response and Resistance Tracy G Lively
Organizing Commitee Tracy G Lively, Milburn Jessup
Scientific Commitee Janet Dancey, Michael Birrer, Lalitha Shankar, Kevin Dobbin
August 13, 2008 Advances In Cancer Vaccines Vaccine, Immunotherapy and the Immunological Constant or Rejection Francesco M Marincola
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Faculty James Doroshow, Giuseppe Giaccone
Panel Discussion Jeffrey S Abrams
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
cancer genetics-- Neurofibromatosis Type 1: The Development and Treatment of Neural Tumors Brigitte C. Widemann
clinical trials-- The End of P Values? Why Alternative Methods to Making Inferences May Be Superior Steven Hirschfeld
developmental therapeutics-- DNA Repair Modulators Yves Pommier
genitourinary cancer-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
lymphoma and plasma cell disorders-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
patient and survivor care-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
patient and survivor care-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
pediatric cancer-- Neurofibromatosis Type 1: The Development and Treatment of Neural Tumors Brigitte C. Widemann
special sessions-- Opening Ceremony with Presidential Address, NCI Director’s Address, The ASCO Cancer Foundation Donor Appreciation Awards, and Karnofsky Memorial Award Lecture John E. Niederhuber
tumor biology-- Molecular and Pharmacokinetic Aspects of Brain Metastases (M04) Patricia Steeg
meet the professor sessions-- Molecular and Pharmacokinetic Aspects of Brain Metastases (M04) Patricia Steeg
meet the professor sessions-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
March 25, 2008 R&D Risk Mitigation Expression of Genes and microRNAs as Biomarkers of Hematopoietic Stem Cell Potency David Stroncek
The Challenges of Biomarker Validation in the Clinical Setting Stephen M Hewitt
March 25, 2008 Clinical Trials Asia Best Practices for Engaging Regulatory Authorities in Asia Sudhir Srivastava
March 25, 2008 Preclinical Development Imaging as a Biomarker in Oncology Drug Trials and Improving Cancer Patient Care Gary J. Kelloff
March 25, 2008 TRANSLATIONAL MEDICINE The Challenges of Biomarker Validation in the Clinical Setting Stephen M Hewitt
Expression of Genes and microRNAs as Biomarkers of Hematopoietic Stem Cell Potency David Stroncek
RNA Amplification as an Essential Approach for Biomarker Discovery Ena Wang
Imaging as a Biomarker in Oncology Drug Trials and Improving Cancer Patient Care Gary J. Kelloff
March 25, 2008 CYTOKINE-BASED THERAPEUTICS CNS Inflammatory Diseases Charles E Egwuagu
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic SESSION A: GRANT WRITING AND INTERNATIONAL FUNDING SOURCES Suresh Mohla
Grant Writing and Funding Opportunities at the NCI Suresh Mohla
A Rose between Two Thorns: Selecting the Right Journal Margaret A. Tucker
Title to be announced Michael Birrer
Molecular Profiling of Cancer: Challenges and Opportunities Paul Meltzer
The Promise of Genome-wide Association Studies Margaret A. Tucker
March 9, 2008 DNA DAMAGE, MUTATION & CANCER Base Excision Repair Variation in the Human Population David M Wilson
Suppression of DNA-damage-induced Chromosomal Rearrangements by Damage Avoidance and Other Pathways Kyungjae Myung
March 4, 2008 Maintenance of Genome Stability Conference 2008 Session 6: The DDR as a barrier to cancer (Chair: Dan Gottschling) Andre Nussenzweig
March 2, 2008 MOLECULAR MECHANISMS IN LYMPHATIC FUNCTION & DISEASE TRANSCRIPTIONAL REGULATION OF ADIPOGENESIS AND LYMPHANGIOGENESIS Brant Weinstein
Studying early lymphatic development using the zebrafish Brant Weinstein
February 17, 2008 GRC - Glycolipid & Sphingolipid Biology Sphingosine-1-phosphate metabolism, a regulator of inflammation and immunity Laura Allende
February 12, 2008 NF-kappaB Genetic Analysis of NF-kappaB Function Ranjan Sen
NF-kappaB and the Adaptive Immune System Ulrich K. Siebenlist
NF-kappaB, Inflammation and Cancer Carter Van Waes, Louis M. Staudt
Workshop 3: NF-kappaB in the Immune Response Ulrich K. Siebenlist
February 10, 2008 GRC - Prolactin & Growth Hormone Family Stem Cells and the Mammary Microenvironment Gilbert H Smith
February 10, 2008 GRC - Plasminogen Activation & Extracellular Proteolysis Matriptase and its inhibitors - balancing cell surface proteolysis during tissue morphogenesis and cancer Roman Szabo
Late Breaking Hot Topics from Abstracts Thomas H Bugge
Reengineering bacterial cytotoxins for protease imaging and tumor targeting Thomas H Bugge
December 1, 2007 47TH American Socieity of Cell Biology Membrane Dynamics Jennifer Lippincott-Schwartz
The C-terminal Extension of hCenexin1 Is Critical for Proper Recruitment and Mitotic Functions of Mammalian Polo-like L. Yu, T. Veenstra
Adhesions and Myosins (Room 204 A/B) Robert S Adelstein
Cell Matrix Interactions (Room 140A) Kenneth. M. Yamada
Advances in Bone Cell Molecular Biology: Epigenetic Control Michael Bustin, Gordon L. Hager
Cellular Biology of Gap Junction Channels (Room 103A) Richard Francis
High Performance Image Analysis and Photomanipulative Techniques for Gordon L. Hager
Dynamics of Rafts, Stabilized Rafts, and Other Non-Raft Domains of Jennifer Lippincott-Schwartz
The NCI Alliance for Nanotechnology in Cancer: Creating Next Piotr Grodzinski
Seeing in The Dark: How Fluorescent Proteins Are Shaping Biology Jennifer Lippincott-Schwartz
Lamin A-dependent Misregulation of Adult Stem Cells Associated with Accelerated Aging. T Misteli
The Arf1 GAP Centaurin Gamma-2/AGAP1 Modulates Neuronal Differentiation. P Randazzo
VEGF Controls Endothelial Cell Permeability by the Endocytosis of VE-cadherin J. Silvio Gutkind,
Understanding the Cell Migration Engine Using High-Resolution Quantitative Light Microscopy Clare M Waterman
A Molecular Mechanism for Aging-related Loss of Heterochromatin and DNA Damage. G Pegoraro, T Misteli
NSBP1: A Novel Protein Which Binds Specifi cally to Nucleosome in Euchromatin and Affects Cellular Differentiation. M Rochman, Michael Bustin
Global Interactions of the Glucocorticoid Receptor Require Extensive Chromatin Remodeling. M Sung, S. John, T A Johnson, P S Meltzer, J Stamatoyannopoulos, Gordon L. Hager
Supported by Merck Research Laboratories:RNA Silencing Mechanisms Natasha J Caplen
Applications of RNAi Screens in the Study of Cancer-associated Processes John N Weinstein, Natasha J Caplen, K Huppi
Intercellular Transfer as a Mechanism of Cell Communication within the Hematopoietic Progenitor Niche. Jennifer M Gillette, Jennifer Lippincott-Schwartz
Role of Mitochondrial Remodeling in Programmed Cell Death in Drosophila melanogaster Richard Youle, B Fell
G1 to S Phase Cell Cycle Progression Requires a Single Electrically-coupled Mitochondrial Network with a Continuous Kasturi Mitra, Jennifer Lippincott-Schwartz
Analysis of Myosin II-induced Maturation of Focal Adhesions. Clare M Waterman
Vesicular Traffi cking and Protein Synthesis Are Required for Streaming during Chemotaxis Carole A Parent, Guofeng Zhang, Paul W Kriebel, Valarie A Barr
Mechanisms of Membrane Traffi cking Juan S Bonifacino
The Complexity of Phosphorylated H2AX Foci and DNA Repair Protein Assembly at DNA Double-stranded Breaks William M Bonner
Structural Analysis of Dynamin Family Members Offers Insight into Membrane Fission Jason A Mears
The AP4 Complex Mediates Sorting of the Amyloid Precursor Protein at the trans-Golgi Network Juan S Bonifacino
Actin Dynamics Regulate a Biophysical Maturation Switch in Focal Adhesions. Clare M Waterman
Effects of O-GlcNAcase on Insulin Signaling in Adipocytes D. Love
November 29, 2007 Fourth Annual In Vivo Molecular Imaging: Bridging the Gap from Discovery to Clinical Applications Nov (29-30) Imaging Tools - Novel Developments (08:25-13:40) Jacek Capala
Imaging Tools - Novel Developments: A New Molecular Tracer for In Vivo Monitoring of HER2 Expression by Positron Emission Tomography (08:30-09:00) Jacek Capala
Clinical Applications (13:40-17:30) Hisataka Kobayashi
Clinical Applications: Multiplexing Probes for in vivo Molecular Imaging (14:15-14:45) Hisataka Kobayashi
November 27, 2007 Fourth Annual In Vitro Molecular Imaging: From Fluorescent Probes to Novel Techniques to Celluar Imaging Nov (27-28) Cellular Imaging (13:45-17:15) Erik M Shapiro
Cellular Imaging: Sizing up Cellular MRI with Micron Sized Iron Oxide Particles (14:15-14:45) Erik M Shapiro
November 15, 2007 2007 Fourth International Conference 1. Integrative Oncology Education Models Panel Patrick J. Mansky
1. Integrative Oncology Education Models Panel Patrick J. Mansky
November 15, 2007 The Joint Meeting of the 4th ISC International Conference on Cancer Therapeutics and The 7th Princess Margaret Hospital Conference: New Developments in Cancer Management Session II: Lung Cancer Giuseppe Giaccone
The role of platinum in the treatment of elderly patients with NSCLC Nagahiro Saijo
Surgical debate: Is there a role for surgery in stage IIIA NSCLC? Giuseppe Giaccone
November 15, 2007 Second Annual Drug Development India : Planning and Managing Drug Discovery & Development Activities Nov(15-16) PRECLINICAL DEVELOPMENT AND CHALLENGES: CO-PRESENTATION : Overcoming the Regulatory Environment Hurdles in Setting up Vivarium and In Vivo Drug Discovery Resource (16:00-16:30) Suresh Poosala
PRECLINICAL DEVELOPMENT AND CHALLENGES (15:30-18:45) Suresh Poosala
November 12, 2007 Well Characterized Biologicals - Continuous Evolution of Chemo- and Bioanalytical Approaches Nov(12 - 14) Causes and Assessment of Product and Process-Related Impurities (13:25-18:30) Allen Minton, Patrick H. Brown
Causes and Assessment of Product and Process-Related Impurities:Detection of Antibody Trace Aggregates by Sedimentation Velocity Analytical Ultracentrifugation (15:30-16:00) Peter Schuck, Patrick H. Brown
Causes and Assessment of Product and Process-Related Impurities:Concentration-Dependant Aggregation of Proteins (14:30-15:00) Allen Minton
November 4, 2007 AACR Centennial Conference: Translational Cancer Medicine Plenary Session 3: Animal Systems and Imaging in Cancer Research Huynh HUNG
Plenary Session 4: New Trials and Genomic-based Design James H. DOROSHOW
Plenary Session 6: Clinical Intervention and Populations Outcomes: Global Strategies Douglas R LOWY
November 4, 2007 2007 International Symposium On Protein Modification And Degradation Ubiquitin ligase machinery: From plant biology to human diseases Allan Weissman
October 17, 2007 Exploring Next Generation Sequencing: Applications and Case Studies (Oct 17-18) TECHnology Platform EXPO (08:25-12:00) Meredith Yeager
Roundtable Discussion: Challenges and Opportunities - Where are We Now? (11:20-12:00) Meredith Yeager
Genome Resequencing for Mutation Screening (13:30-18:30) Meredith Yeager
Genome Resequencing for Mutation Screening: Common Variation at 8q24 and Prostate Cancer Risk (17:00-17:30) Meredith Yeager
Bioinformatics (15:30-17:30) Elliott H. Margulies
Bioinformatics: ENCODE Pilot Project and the Future of Comparative Sequence Analysis (17:00-17:30) Elliott H. Margulies
October 17, 2007 Inaugral Nuclear Harmone Receptors Modulators: Targets for Drug Discovery Oct (17-18) NUCLEAR HORMONE RECEPTORS (14:10-18:50) John Cidlowski
NUCLEAR HORMONE RECEPTORS: Glucocorticoid Receptors: Old Targets that Need New Drugs (14:45-15:15) John Cidlowski
DISCOVERY CHEMISTRY (08:35-12:55) William T. Schrader
DISCOVERY CHEMISTRY: Chairperson’s Remarks (08:35-08:40) William T. Schrader
INNOVATIVE TECHNOLOGIES FOR NHR MODULATORS (13:55-17:10) William T. Schrader
INNOVATIVE TECHNOLOGIES FOR NHR MODULATORS: Chairperson’s Remarks (13:55-14:00) William T. Schrader
October 16, 2007 Fifth Annual RNAi for Drug Discovery and Therapeutics - Best Practices from the Bench to the Clinic Oct (16-17) RNAi Targets and Cancer Biology: Applications of RNAi Screens in the Study of Cancer-associated Processes (11:40-12:10) Natasha J Caplen
October 15, 2007 2nd Annual Innovations in Clinical Trials: Implementations of Biomarkers (Oct15-16) Colorectal Adenomas: A Prototype for the Use of Surrogate End Points in the Development of Cancer Prevention Drugs (10:00-10:30) Gary J. Kelloff
ADDRESSING THE VALIDATION BOTTLENECK (Featured Speaker) Proteomic Technologies for Cancer Research: A Strategic Plan for Translating Discoveries to the Clinic (11:15-11:45) Henry Rodriguez
ADDRESSING THE VALIDATION BOTTLENECK (11:10-13:25) Henry Rodriguez
October 15, 2007 Thirs Annual Quantitative PCR, MicroArrays, And Biologican Validation: Capturing the Complete Biological Story (Oct 15-17) Managing Data (09:30-12:30) Richard A. Lempicki
Managing Data: Decipher Biologic Pathways and Determine the Total “Omic” Picture with an Integrated DAVID Knowledgebase (09:35-10:05) Richard A. Lempicki
TECHnology Platform EXPO (08:25-12:00) Meredith Yeager
Roundtable Discussion: Challenges and Opportunities - Where are We Now? (11:20-12:00) Meredith Yeager
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Third annual Genomic Biomarkers: BIOMARKER DATA ANALYSIS: Decipher and Select the Genomic Biomarkers with the DAVID Bioinformatics Resources (17:30-18:00) Richard A. Lempicki
Third annual Genomic Biomarkers: BIOMARKER DATA ANALYSIS (16:00-18:00) Richard A. Lempicki, Brian Luke
Third annual Genomic Biomarkers: BIOMARKER DATA ANALYSIS: Comparing Fingerprint-based and Biomarker-based Classifiers (16:00-16:30) Brian Luke
Fifth Annual Protein Biomarkers; BIOMARKER DATA ANALYSIS: Comparing Fingerprint-based and Biomarker-based Classifiers (16:00-16:30) Brian Luke
Fifth Annual Protein Biomarkers; BIOMARKER DATA ANALYSIS (16:00-18:00) Richard A. Lempicki, Brian Luke
Fifth Annual Protein Biomarkers; BIOMARKER DATA ANALYSIS: Decipher and Select the Genomic Biomarkers with the DAVID Bioinformatics Resources (17:30-18:00) Richard A. Lempicki
September 7, 2007 The 2007 Breast Symposium General Session VIII: Preoperative Therapy: Who and Why? 3:45 PM — 5:30 PM JoAnne Zujewski
August 11, 2007 Gastrointestinal Tract XII: The Molecular and Integrative Basis for GI Development, Homeostasis and Disease Digestive and Respiratory Sciences IRGs Scientific Review Mushtaq A Khan
How to write/prepare a K-type award Robert Karp, Jill Carrington
August 11, 2007 Lipid signaling Pathways in Cancer “C1, see them all? Opportunities for selectivity with ligands targeted to C1 domains Peter M Blumberg
August 4, 2007 Obesity, Energy Balance and Disease Interactive effects of diet and exercise on gene expression in C57BL/6 mouse mammary glands” David Berrigan
July 21, 2007 Hematopoietic Malignancies A cell-cycle independent function of tumor suppressor Ink4b in regulation of lineage choice” Linda Wolff
The ability of CBFβ-SMMHC to repress RUNX1 does not correlate with its ability to induce leukemia Paul Liu
Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma Christina Annunziata
DNA damage and oncogenic stress: barriers to chromosomal translocations Andre Nussenzweig
July 14, 2007 BIOLOGY OF CALPAINS IN HEALTH AND DISEASE Aortic calpain 1 increases with aging and mediates angiotensin II signaling) Liqun Jiang
July 14, 2007 Skeletal Muscle Satellite & Stem Cells MicroRNA-214 modulates the expression of Polycomb Ezh2 methyltransferase to control skeletal muscle development Aster Juan
July 7, 2007 CHROMATIN AND TRANSCRIPTION Chromatin remodeling by Brg1 regulates gene expression and chromatin structure during T cell differentiation Mike Pazin
Activation of the yeast HIS3 gene results in a highly dynamic chromatin structure David Clark
Biochemistry of histone variant deposition in S. cerevisiae Carl Wu
Genome wide interaction of nuclear receptors with chromatin Gordon L. Hager
Mechanism of barrier insulation Gary Felsenfeld
Cell cycle control of centromeric repeat transcription Ee Sin Chen
July 7, 2007 Protein Kinases and Protein Phosphorylation Regulation of Raf-MEK-ERK cascade signaling Deborah Morrison
Self-controlled mechanism of Plk1 localization to the kinetochores is important for proper chromosome segregation Kyung S Lee
Loss of p53 suppresses senescence in Cdk2-/-Cdk4-/- MEFs V.C Padmakumar
June 22, 2007 CNRS - Conférences du Vivant “Arf Family GTPases� Arf Activation Complexes that Couple Signal Input to Downstream Effectors Catherine Jackson
Structural Determinants of Localization and Molecular Complex Formation by BIG1 and BIG2 J Moss
Involvement of Arf Metabolism in Poliovirus RNA Replication Ellie Ehrenfeld
New Insights into Arf Functioning at the Golgi Complex and Plasma Membrane JULIE G DONALDSON
June 16, 2007 Nuclear Structure and Cancer Organization of Chromatin and Histone Modifications at a James G McNally
June 16, 2007 Thrombospondins and other Matricellular Proteins In Tissue Organization and Homeostasis Immune Cell Function David D Roberts
Therapeutic Applications David D Roberts
Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts Jeff S Isenberg
June 9, 2007 Ion Channel Regulation New players in the game James W Putney
June 9, 2007 Mitosis: Spindle Assembly and Function Moonlighting in mitosis: Nucleoporins at kinetochores Mary Dasso
June 9, 2007 Transport ATPases: Structure, Mechanisms, Genomics and Disease ABC Transporters-Evolution, Variation and Human Disease Michael Dean
Synonymous mutations affect function of the multidrug transporter Suresh Ambudkar
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.